João Lacerda

Has grant

Full Professor of Medicine

Universidade do Porto Faculdade de Medicina

Portugal

Research Interests

Explore related searches

Professors in Portugal Professors in Immunology Immunology professors in Portugal

Contact this professor

ORCID

Google Scholar

Academic Page

Recent Grants

Grant: Close

CMV infection and CMV-specific T-cell reconstitution in unrelated donor allo-HSCT after in vivo T-cell depletion with ATG: a comparative study of prophlylaxis with letermovir versus standard of care preemptive treatment

Open Date: 2020-01-01

Close Date: 2022-01-01

Grant: Close

Repair of tissue and organ damage in refractory chronic graft versus host disease after hematopoietic stem cell transplantation by the infusion of purified allogeneic donor regulatory T lymphocytes

Open Date: 2015-01-01

Close Date: 2019-12-31

Grant: Close

Induction of Immune Tolerance in Human Allogeneic Hematopoietic Stem Cell Transplantation

Open Date: 2013-03-01

Close Date: 2016-03-01

Grant: Close

Clinical implications of activation of PI3K/Akt signaling pathway in primary adult ALL

Open Date: 2009-01-01

Close Date: 2012-07-01

João Lacerda

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (20)

Disseminated intravascular coagulation score evolution in 48 h predicts early death in acute promyelocytic leukemia patients

Full-Dose Azacitidine in 5 Days Versus 7 Days With a Weekend Break in Myelodysplastic Syndromes: A Retrospective Cohort Study

Aspergillus fumigatus hijacks human p11 to redirect fungal-containing phagosomes to non-degradative pathway

Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers.

Cerebral venous thrombosis as a first presentation of a high-risk acute myeloid leukaemia

HLA frequency distribution of the Portuguese bone marrow donor registry

Predictors of very early death in acute promyelocytic leukemia: a retrospective real-world cohort study

Editorial: Regulatory T cells in graft versus host disease

Hematopoietic Stem Cell Transplantation for Neurological Disorders: A Focus on Inborn Errors of Metabolism

A phase 1 study of donor regulatory T-cell infusion plus low-dose interleukin-2 for steroid-refractory chronic graft-vs-host disease

Cell-based therapy in prophylaxis and treatment of chronic graft-versus-host disease.

Cumulative Organ Dysfunction and Functional Status before and after Intensive Care Unit Admission Are Strong Predictors of Mortality in Patients with Hematologic Malignancies

Serum amyloid P component is an essential element of resistance against Aspergillus fumigatus.

Chronic lymphocytic leukaemia/small lymphocytic lymphoma treatment with rituximab and high‐dose methylprednisolone, revisited

Genetic Variation in PFKFB3 Impairs Antifungal Immunometabolic Responses and Predisposes to Invasive Pulmonary Aspergillosis

Suppression by Allogeneic-Specific Regulatory T Cells Is Dependent on the Degree of HLA Compatibility

Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease.

Disseminated Intravascular Coagulation Score Evolution in 48 Hours Predicts Early Death in Newly-Diagnosed Chemotherapy-Treated Acute Promyelocytic Leukemia Patients

Flotillin-dependent lipid-raft microdomains are required for functional phagolysosomes against fungal infections

Phagosomal removal of fungal melanin reprograms macrophage metabolism to promote antifungal immunity.

Collaborators (6)

Rachel Crossland

Agostinho Carvalho

ANTONIO INFORZATO

Ronjon Chakraverty

Sandra Costa

Thomas Krüger

How do I reach out?

Meet Kite AI